Balance Sheet Components (Tables)

6 Months Ended

Jun. 30, 2023

Balance Sheet Related Disclosures [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consisted of the following (in thousands):

	June 30, 2023		December 31, 2022
Prepaid research and development	$	4,470	$	4,840
Prepaid clinical trial		2,972		2,119
Deferred offering costs		724		724
Prepaid insurance		333		388
Prepaid bonus		23		18
Other		510		448
Total prepaid expenses and other current assets	$	9,032	$	8,537

Schedule of Property Plant and Equipment Net

Property, plant and equipment, net consisted of the following (in thousands):

	June 30, 2023			December 31, 2022
Leasehold improvements	$	2,091		$	2,091
Laboratory equipment		2,868			2,868
Computer equipment		1,115			1,115
Furniture and fixtures		878			898
Construction in progress		9,498			9,633
		16,450			16,605
Accumulated depreciation		(2,311	)		(1,642	)
Property, plant and equipment, net	$	14,139		$	14,963

Schedule of Accrued Expense and Other Current Labilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	June 30, 2023		December 31, 2022
Accrued research and development	$	7,016	$	8,190
Accrued license fees		3,500		—
Accrued clinical trial		2,159		1,473
Accrued compensation		2,049		2,519
Accrued severance		1,754		1,463
Lease liabilities, current portion		1,638		1,521
Accrued professional and consulting fees		580		390
Warrant liability		252		—
Accrued property, plant and equipment		—		2,081
Other		684		650
Total accrued expenses and other current liabilities	$	19,632	$	18,287